49+ Triple Negative Breast Cancer Metastasis
Background. 54±11) who had no signs of distant metastasis at initial diagnosis were used for the search for metastasis predictor genes. Most frequent sites of metastasis.
This is because the cancer cells do not have the estrogen or progesterone receptors or enough of the her2 protein to make hormone therapy or targeted drugs work. There are currently no targeted therapies to treat tnbc. This retrospective study reviewed the pattern of distant metastasis with regard to survival in patients with tnbc.
54±11) who had no signs of distant metastasis at initial diagnosis were used for the search for metastasis predictor genes.
However, if the cancer does not return within 5 years. At the 2018 metastatic breast cancer forum, nancy lin, md, and geoffrey shapiro, md, phd, discuss research advances in the treatment of triple negative. This retrospective study reviewed the pattern of distant metastasis with regard to survival in patients with tnbc. It is characterized by its unique molecular profile, aggressive behavior, distinct patterns of metastasis, and lack of targeted therapies.